First Trust NYSE Arca Biotechnology UCITS ETF Acc

ISIN IE00BL0L0H60

 | 

Ticker FBT

TER
0.60% p.a.
Distribution policy
Accumulating
Replication
Full replication
Fund size
6 m
Holdings
30
 

Overview

Description

The First Trust NYSE Arca Biotechnology UCITS ETF Acc seeks to track the NYSE Arca Biotechnology index. The NYSE Arca Biotechnology index tracks companies operating in the biotechnology industry which are listed on NYSE or Nasdaq.
 
The ETF's TER (total expense ratio) amounts to 0.60% p.a.. The First Trust NYSE Arca Biotechnology UCITS ETF Acc is the only ETF that tracks the NYSE Arca Biotechnology index. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The First Trust NYSE Arca Biotechnology UCITS ETF Acc is a very small ETF with 6m GBP assets under management. The ETF was launched on 27 May 2020 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Fund size
GBP 6 m
Total expense ratio
0.60% p.a.
Replication Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in GBP)
18.14%
Inception/ Listing Date 27 May 2020
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider First Trust
Germany 30% tax rebate
Switzerland No ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype Total return index
Swap counterparty -
Collateral manager
Securities lending No
Securities lending counterparty

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the First Trust NYSE Arca Biotechnology UCITS ETF Acc.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our new ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the First Trust NYSE Arca Biotechnology UCITS ETF Acc.

Top 10 Holdings

Weight of top 10 holdings
out of 30
37.72%
Natera
4.77%
Bruker
4.08%
Halozyme Therapeutics
3.89%
Repligen Corp
3.76%
Waters
3.68%
Mettler-Toledo Intl
3.54%
Alkermes
3.54%
Intra-Cellular Therapies
3.52%
PTC Therapeutics
3.47%
Regeneron Pharmaceuticals
3.47%

Countries

United States
86.77%
Ireland
3.54%
Other
9.69%

Sectors

Health Care
90.31%
Other
9.69%
As of 29/02/2024

Performance

Returns overview

YTD -5.21%
1 month -0.90%
3 months -3.17%
6 months -1.17%
1 year -6.63%
3 years -0.14%
5 years -
Since inception (MAX) -12.22%
2023 -3.32%
2022 +6.81%
2021 -2.52%
2020 -

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 18.14%
Volatility 3 years 22.83%
Volatility 5 years -
Return per risk 1 year -0.36
Return per risk 3 years 0.00
Return per risk 5 years -
Maximum drawdown 1 year -15.14%
Maximum drawdown 3 years -20.96%
Maximum drawdown 5 years -
Maximum drawdown since inception -29.26%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
Borsa Italiana EUR FBT FBT IM
FBTINAV
FBT.MI
London Stock Exchange GBX FBT FBT LN
FBTINAV

London Stock Exchange GBP - FBT LN

London Stock Exchange USD FBTU FBTU LN
FBTINAV

Further information

Further ETFs with similar investment focus

Fund name Fund Size in m € (AuM) TER p.a. Distribution Replication
Invesco Nasdaq Biotech UCITS ETF 585 0.40% p.a. Accumulating Swap-based
iShares Nasdaq US Biotechnology UCITS ETF 424 0.35% p.a. Accumulating Sampling
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 40 0.35% p.a. Distributing Sampling

Frequently asked questions

What is the name of FBT?

The name of FBT is First Trust NYSE Arca Biotechnology UCITS ETF Acc.

What is the ticker of First Trust NYSE Arca Biotechnology UCITS ETF Acc?

The primary ticker of First Trust NYSE Arca Biotechnology UCITS ETF Acc is FBT.

What is the ISIN of First Trust NYSE Arca Biotechnology UCITS ETF Acc?

The ISIN of First Trust NYSE Arca Biotechnology UCITS ETF Acc is IE00BL0L0H60.

What are the costs of First Trust NYSE Arca Biotechnology UCITS ETF Acc?

The total expense ratio (TER) of First Trust NYSE Arca Biotechnology UCITS ETF Acc amounts to 0.60% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is First Trust NYSE Arca Biotechnology UCITS ETF Acc paying dividends?

First Trust NYSE Arca Biotechnology UCITS ETF Acc is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of First Trust NYSE Arca Biotechnology UCITS ETF Acc?

The fund size of First Trust NYSE Arca Biotechnology UCITS ETF Acc is 6m GBP. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.